| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |